Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: resembling (46)

Cyclophosphamide-Epirubicin-Paclitaxel(7 day)

Description: Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE-EPIRUBICIN-PACLITAXEL (7 day) Regimen • Breast Cancer – Cyclophosphamide-Epirubicin-Paclitaxel (7 day) Indication • Neoadjuvant / adjuvant therapy
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Cyclophosphamide-Epirubicin-Paclitaxel-7-day.pdf

Cyclophosphamide-Epirubicin (60)-Fluorouracil (FE60C)

Description: Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE-EPIRUBICIN (60)- FLUOROURACIL Regimen (FE60C) • Breast Cancer – Cyclophosphamide-Epirubicin (60)-Fluorouracil (FE60C) Indication • Metastatic breast cancer
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/FE60C.pdf

Cyclophosphamide-Epirubicin (100)-Fluorouracil (FE100C)

Description: Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE-EPIRUBICIN (100)- FLUOROURACIL Regimen (FE100C) • Breast Cancer – Cyclophosphamide-Epirubicin (100)-Fluorouracil (FE100C) Indication • Neo-adjuvant /adjuvant
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/FE100C.pdf

Cyclophosphamide-Doxorubicin-Paclitaxel

Description: Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE-DOXORUBICIN-PACLITAXEL (21 day) Regimen • Breast Cancer – Cyclophosphamide-Doxorubicin-Paclitaxel (21 day) Indication • Neoadjuvant / adjuvant therapy
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Cyclophosphamide-Doxorubicin-Paclitaxel.pdf

Cyclophosphamide-Docetaxel-Doxorubicin Ver 1.1

Description: Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE-DOCETAXEL-DOXORUBICIN Regimen (TAC) Breast Cancer – Cyclophosphamide-Docetaxel-Doxorubicin (TAC) Indication Adjuvant therapy for node positive
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/BreastCyclophosphamideDocetaxelDoxorubicinTACVer11.pdf

Cyclophosphamide-Docetaxel Ver 1.1

Description: Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE-DOCETAXEL Regimen Breast Cancer – Cyclophosphamide-Docetaxel Indication Adjuvant therapy for early breast cancer when anthracyclines are
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/BreastCyclophosphamideDocetaxelVer11.pdf

Cyclophosphamide (PO)-Fluorouracil-Methotrexate (CMF PO)

Description: Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE (PO)-FLUOROURACIL-METHOTREXATE (CMF-PO) Regimen • Breast Cancer – Cyclophosphamide (PO)-Fluorouracil-Methotrexate (CMF PO) Indication • Adjuvant
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/CyclophosphamideFluorouracilMethotrexateCMF-PO.pdf

Cyclophosphamide (IV)-Fluorouracil-Methotrexate (CMF IV)

Description: Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE–FLUOROURACIL-METHOTREXATE (CMF IV) Regimen • Breast Cancer – Cyclophosphamide IV-Fluorouracil-Methotrexate (CMF IV) Indication • Adjuvant treatment
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/CyclophosphamideFluorouracilMethotrexateCMF-IV.pdf

Capecitabine-Lapatinib

Description: Chemotherapy Protocol BREAST CANCER CAPECITABINE-LAPATINIB This protocol may require funding Regimen • Breast Cancer – Capecitabine-Lapatinib Indication • Treatment of locally advanced
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/CapecitabineLapatinib.pdf

Lomustine-Procarbazine-Vincristine (PCV) ver 1.1

Description: Chemotherapy Protocol Central Nervous System LOMUSTINE-PROCARBAZINE-VINCRISTINE (PCV) Regimen CNS – Lomustine-Procarbazine-Vincristine (PCV) Indication Adjuvant treatment for grade III
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CNS/Lomustine-Procarbazine-Vincristine-PCV-ver-1.1.pdf

521 to 530 of 761

Previous … 51 52 53 54 55 … Next